Delivery Order SPE2DE22D0008-SPE2D625F23XA

Award Date 1/13/25
Potential Completion Date 1/16/25
Potential Value $23K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the delivery of ALBACLONE Anti-A blood typing reagents to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,555.00 firm-fixed-price contract has a period of performance through June 13, 2024 and was awarded on June 10, 2024. Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized blood banking products and services to federal...
This federal contract award, with an ID of SPE2DE22D0008|SPE2D624F2LS5, was issued by the Defense Logistics Agency Troop Support Medical to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the delivery of ALBACLONE anti-LEA blood bank products. The $2,286.60 firm fixed price contract has a completion date of July 11, 2024. It is not designated as a set-aside contract. Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized...
This federal contract award SPE2DE22D0008|SPE2D625F22W7 was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, and quality control materials. The $5,160.00 firm fixed-price delivery order contract is for the provision of ALBACYTE antibody identification panels, a critical product supporting blood banking operations across federal healthcare systems. Alba Bioscience, a...
This federal contract award, SPE2DE22D0008|SPE2D625F15SN, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a for-profit organization and subsidiary of Quotient Biodiagnostics, Inc. The contract, valued at $1,062.00, is for the delivery of ALBACYTE antibody screening (2-cell) products, which are critical in-vitro diagnostic medical supplies used for blood banking operations across federal healthcare systems, particularly the Department of Veterans Affairs (VA), DLA,...
This federal contract award, with the ID SPE2DE22D0008|SPE2D624F7DW1, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The $1,906.00 firm-fixed-price contract is for the delivery of ALBACYTE antibody screening (3-cell) products, with a period of performance ending on October 8, 2024. Alba Bioscience is a...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The $1,118.00 Firm Fixed Price Delivery Order (SPE2DE22D0008|SPE2D625F38A1) is for the product "ALBACLONE ANTI-A" and has an ultimate completion date of December...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking supplies. The contract, valued at $4,582.00, is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the provision of ALBACYTE Antibody ID Panels, which are specialized blood banking products used for diagnostic testing, blood typing, and transfusion...
This federal contract award, valued at $7,590.00, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other specialized biomedical products to various federal agencies. The contract is for the delivery of ALBACYTE Antibody ID Panels, which are essential blood banking supplies used to support the DLA's medical operations. Alba Bioscience holds multiple...
This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $2,370.00, is for the delivery of ALBACLONE anti-B products. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract type. Alba...
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the supply of specialized in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $6,750.00, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to support defense medical operations. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement...
  • SPE2DE22D0008
    Indefinite Delivery Contract
  • SPE2DE22D0008-SPE2D625F23XA
    Delivery Order

This federal contract award with ID SPE2DE22D0008|SPE2D625F23XA was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a for-profit organization and subsidiary of Quotient Biodiagnostics, Inc. The $22,550.00 firm fixed-price contract is for the delivery of ALBACLONE Anti-D Blend products, which are specialized blood banking reagents and diagnostic materials used for blood typing and transfusion services in federal healthcare facilities.

The contract does not have a set-aside designation and is expected to be completed by January 16, 2025. Alba Bioscience is an established supplier of in vitro diagnostics, blood bank reagents, and quality control materials to federal agencies, particularly the Department of Veterans Affairs (VA), DLA, and Department of Health and Human Services (HHS). The company holds two significant Blanket Purchase Agreements (BPAs) with the VA, valued at $109,420.35 and $30,000, for the provision of red blood cell reagents and other blood banking supplies to VA medical facilities.

Generated 4/14/25, 10:33 AM